Latest Insights on DNA
Intellia-gent Investing, Tesla’s Not-A-Recall & Binance Schminance June 28, 2021 Great Stuff Wall Street’s Weird Science ♫ From my heart and from my hand, why don’t people understand … my intentions? ♫ Great Ones, did you see what happened in the biotech market today? Holy cow … it was poetry in motion. Intellia Therapeutics (Nasdaq: ) skyrocketed more than 50% after early trial data showed the company’s […]
Genes Get Wilder: 23andMe, You & Big Brother June 19, 2021 Great Stuff What’s The Deal With 23andMe? Great Ones, what do you know about 23andMe (Nasdaq: )? Some of you probably know 23andMe from its home testing kits. No, not home drug tests — genetic tests that tell you where your ancestors came from. 23andMe’s tests were a popular holiday/birthday gift a few years ago. According to […]
Nvidia ARM Wrestles U.K., AMD Scores With Google & Trade Desk Decimated June 18, 2021 Great Stuff Friday Four Play: The “AnARMchy In The U.K.” Edition Great Ones, have you checked in on your Nvidia (Nasdaq: ) position lately? What Nvidia position? You know, the one I recommended not three weeks ago in Great Stuff’s weekend edition: “What’s The Deal With Nvidia?” I made it an official Great Stuff Picks recommendation too. […]
New Biotech SPACs Could Help Spark a Rally June 8, 2021 Investment Opportunities, Technology, Winning Investor Daily One venture capitalist’s decision to specifically target biotech companies suggests the industry presents the highest return potential.
You Can Save Lives and Profit by Investing in This Mega Trend May 5, 2021 American Investor Today, Investment Opportunities, Technology (4-minute read) You don’t need to be a molecular biologist to understand this technology. It not only saves lives, it could also hand you profits in the years ahead… MEET OUR EXPERTS
Chief Investment Strategist of Money & Markets
Director of VIP Services
Research Analyst
Founder of Weekend Trader
Chief Strategist of Strategic Fortunes and three elite services
Founder of TRADEMONSTER.ai
